How effective is folfox chemotherapy?

How effective is folfox chemotherapy?

The researchers found that the 213 patients in the study had a 5-year overall survival rate of 77.9 percent. They found FOLFOX significantly increased the overall survival rate in patients who received at least eight cycles.

Does folfox get worse?

Patients usually say that they are at their best during the first 3 days after chemo. After that, you may have a loss of energy and experience a general feeling of being unwell. This feeling of being unwell usually last for 4 to 7 days after treatment, and can continue to worsen after each cycle of treatment.

Is folfox highly emetogenic?

FOLFOX is a moderately emetogenic chemotherapy regimen associated with a significant amount of delayed CINV that remains difficult to control even using standard antiemetic therapy [10].

What does folfox feel like?

Increased risk of getting an infection is due to a drop in white blood cells. Symptoms include a change in temperature, aching muscles, headaches, feeling cold and shivery and generally unwell. You might have other symptoms depending on where the infection is. Infections can sometimes be life threatening.

Can FOLFOX cause heart problems?

The incidence of Takotsubo cardiomyopathy due to 5-fluorouracil based chemotherapeutic regimens like FOLFOX is not uncommon. It is also seen with platinum based chemotherapy. Most of these patients have reversible cardiotoxicity and the cardiac function recovers within a short period with supportive treatment.

Can you work while on FOLFOX?

Myth: You will not be able to work while on chemo. Fact: Most people work full-time on FOLFOX or FOLFIRI, two common chemo drugs. In fact, many find going to work helps by creating a feeling of normalcy and keeping patients busy and their minds off their cancer. The key to this is proper management of side effects.

What is the best antiemetic for chemotherapy?

Low emetogenic chemotherapy Within the first 24 hours, all guidelines recommend dexamethasone as the antiemetic of choice, while dopamine receptor antagonist or 5-HT3 receptor antagonist have been recommended as alternatives to dexamethasone by MASCC/ESMO and NCCN guidelines.

Which chemotherapy agent has the lowest emetogenic potential?

Drugs considered to have low emetogenic risk (10\%-30\%) include the taxanes, etoposide, and biologics such as trastuzumab (Herceptin) and cetuximab (Erbitux). Some antineoplastic agents such as the vinca alkaloids as a class or bevacizumab (Avastin) are associated with minimal risk of emesis without prophylaxis (< 10\%).

How do you know if folfox is working?

The first sign that a treatment is working is often when your symptoms reduce in severity. Your doctor may order blood tests and scans at various time points throughout your treatment to determine how well it is working.